EPGL 499M float; half of 5B O/S held by PriceWaterhouseCoopers; no dilution since day one, when this new medical device company formed from a restructuring in July 2012; has development agreement with Cooper (NYSE: COO) and initial agreement with Intel (Nasdaq: INTC); plans to reduce A/S and O/S on January 30; working on MEMS devices; company has virtually no debt.
Many expect .10+ soon. Company's target price is .88.
Read this article and do your own DD.
http://www.mddionline.com/article/will-epgls-topspin-serve-next-generation-medical-devices
Many expect .10+ soon. Company's target price is .88.
Read this article and do your own DD.
http://www.mddionline.com/article/will-epgls-topspin-serve-next-generation-medical-devices
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
